EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions

Bharathikumar Sivakumar iD, Jason Mathiu Mwenda iD, Benjamin Alan Lopman, Gagandeep Kang, Tintu Varghese iD

Viruses · 21.08.2026 · 18 (8) · 917

DOI: 10.3390/v18080917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 21.08.2026. Verfasst von Bharathikumar Sivakumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Rotavirus Infections. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral, live-attenuated rotavirus vaccines (ORVs) have significantly reduced severe diarrheal disease and deaths; however, vaccine performance in low- and middle-income countries (LMICs) remains lower than in high-income countries. With increasing global use, real-world data now provide important insights into strategies to improve vaccine impact in these settings. This review summarizes current evidence on the effectiveness and impact of ORVs in LMICs, with a focus on approaches to optimize performance, including alternative dosing schedules, booster doses in late infancy, and mixed vaccine regimens. Evidence on vaccine interchangeability offers practical solutions for countries facing supply disruptions and financial constraints. The review also highlights the growing importance of economic sustainability, particularly in the context of transitions from external funding support. Despite lower efficacy, ORVs continue to provide substantial public health benefits in LMICs. Sustained impact will depend on strengthening programme delivery, ensuring stable vaccine supply, and advancing next-generation vaccines. Continued evaluation of effectiveness, cost, and implementation strategies will be critical to maximizing long-term benefits in high-burden settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus VaccinesRotavirus InfectionsHumansDeveloping CountriesVaccine EfficacyAdministration, OralVaccines, AttenuatedRotavirus

Stichwörter der Autor:innen

GAVI-transitionLMICslong-term economic sustainabilityrotavirus vaccinesvaccine effectiveness (VE)vaccine interchangeability

Substanzen

Rotavirus VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India.
  • WHO Regional Office for Africa (WHO/AFRO), Brazzaville P.O. Box 06, Congo.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Center for Public Health, Christian Medical College, Vellore 632004, India.

ORCID-Profile: Bharathikumar Sivakumar, Jason Mathiu Mwenda, Tintu Varghese

Zitieren

APA

Sivakumar, B., Mwenda, J. M., Lopman, B. A., Kang, G., & Varghese, T. (2026). Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions. Viruses, 18(8), 917. https://doi.org/10.3390/v18080917

Vancouver

Sivakumar B, Mwenda JM, Lopman BA, Kang G, Varghese T. Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions. Viruses. 2026;18(8):917. doi:10.3390/v18080917

BibTeX
@article{Sivakumar2026,
  author = {Sivakumar, Bharathikumar and Mwenda, Jason Mathiu and Lopman, Benjamin Alan and Kang, Gagandeep and Varghese, Tintu},
  title = {Performance of Oral Rotavirus Vaccines in Low- and Middle-Income Settings: Current Evidence, Persistent Gaps and Future Directions},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {917},
  doi = {10.3390/v18080917}
}
Kostenlos starten →